annual Report 2009 - STRATEC Biomedical AG

Notes to the Consolidated
Financial Statements
for the 2009 financial year
of STRATEC Biomedical Systems AG
I. Principles and methods
1. General disclosures
STRATEC Biomedical Systems AG (hereinafter “STRATEC AG”) designs and manufactures fully automated systems for its
partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together
with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops
its products on the basis of its own patented technologies.
The legal domicile of STRATEC AG is Gewerbestrasse 37, 75217 Birkenfeld, Germany. Its financial year corresponds to
the calendar year.
The declaration required by § 161 of the German Stock Corporation Act (AktG) in respect of the German Corporate
Governance Code (the “Declaration of Conformity”) was submitted by the Board of Management and Supervisory Board
of STRATEC Biomedical Systems AG on December 18, 2009 and made permanently available to shareholders in the
Investor Relations section of the company’s website (www.stratec-biomedical.de).
Due to its stock market listing in the Prime Standard segment of the regulated market of the Frankfurt Stock Exchange,
STRATEC AG is obliged pursuant to § 315 a (1) of the German Commercial Code (HGB) to prepare consolidated financial
statements in accordance with International Financial Reporting Standards (IFRS).
The consolidated financial statements of STRATEC AG have been compiled in euros. Unless otherwise stated, the amounts
reported in the notes have been stated in thousand euros (u thousand).
2. Application of International Financial Reporting Standards (IFRS)
and presentation of the implications of new accounting standards
The consolidated financial statements prepared by STRATEC AG as the topmost parent company as of December 31, 2009
have been based on uniform accounting and valuation principles. Pursuant to § 315 a of the German Commercial Code
(HGB), application has been made of the International Financial Reporting Standards (IFRS) of the International Accounting
Standards Board (IASB) as adopted by the European Union which are valid as of the balance sheet date. Account has
been taken of the IAS and IFRS applicable as of the balance sheet date, as well as of the Interpretations of the Financial
Reporting Interpretations Committee (IFRIC / SIC) valid for the financial year under report. The requirements of the standards
and interpretations applied have been met without exception. The financial statements are therefore consistent
with IFRS as required by IAS 1.16. The consolidated financial statements of STRATEC AG therefore provide a true and
fair picture of the net asset, financial and earnings position, as well as of the cash flows, of the Group for the financial
year under report.
52 stratec Annual Report 2009